Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury

2013/08/10 by Sen Wang, Hongbin Cheng, Guanghui Dai +7 · 27 citations
Medicine · #Spinal Cord Injury Research #Traumatic Brain Injury Research #Stroke Rehabilitation and Recovery

paper · doi:10.1016/j.brainres.2013.08.001

Cited by

• Mesenchymal stem cell-derived secretome in traumatic brain injury: Stage-specific paracrine mechanisms and translational challenges
• A multifunctional PVA/EPL hydrogel loaded with UCMSC-derived exosomes for enhanced wound healing
• Wharton's Jelly Transplantation Improves Neurologic Function in a Rat Model of Traumatic Brain Injury. [europepmc]
• Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury. [europepmc]
• Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. [europepmc]
• Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. [europepmc]
• Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy. [europepmc]
• Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration. [europepmc]
• Traumatic Brain Injury and Stem Cell: Pathophysiology and Update on Recent Treatment Modalities. [europepmc]
• Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors. [europepmc]
• Application of stem cells in tissue engineering for defense medicine. [europepmc]
• Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1 G93A and NSG animal models. [europepmc]
• Mesenchymal stromal cells as a potential therapeutic for neurological disorders. [europepmc]
• Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). [europepmc]
• Mesenchymal Stem Cells for Regenerative Medicine. [europepmc]
• The TRIM protein Mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury. [europepmc]
• Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury. [europepmc]
• Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches. [europepmc]
• Subjective Cognitive Decline and Related Cognitive Deficits. [europepmc]
• Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI. [europepmc]
• Topography: A Biophysical Approach to Direct the Fate of Mesenchymal Stem Cells in Tissue Engineering Applications. [europepmc]
• What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? [europepmc]
• Current Status and Future Prospects of Perinatal Stem Cells. [europepmc]
• Cell Therapy for Chronic TBI: Interim Analysis of the Randomized Controlled STEMTRA Trial. [europepmc]
• Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials. [europepmc]
• Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury. [europepmc]
• Immune modulation after traumatic brain injury. [europepmc]